C07K 4/04
From bacteria
Official title: from bacteria
C07K4/04 (From bacteria) appears on 30 US grants and 15 published applications in this corpus.
Search patents in C07K- Granted patents
- 30
- Published applications
- 15
- Assignees
- 24
- Inventors
- 85
- Latest grant
- 22 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 2 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 4 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 2 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 1 | 5 |
| 2021 | 1 | 1 |
| 2022 | 2 | 0 |
| 2023 | 1 | 0 |
| 2024 | 1 | 3 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Microbiota sequence variants of tumor-related antigenic epitopes22 Jul 2025US 12,364,743 B2Enterome S.A.
- Compositions and methods for non-myeloablative conditioning26 Nov 2024US 12,152,080 B2Children's Medical Center Corporation
- Microbiota sequence variants of tumor-related antigenic epitopes1 Aug 2023US 11,712,465 B2Enterome S.A.
- Addition of nucleases directly to cell culture to facilitate digestion and clearance of host cell nucleic acids8 Mar 2022US 11,268,071 B2Merck Sharp & Dohme Corp.
- Agrobacterium derived cell penetrating peptides as nanocarriers22 Feb 2022US 11,254,944 B2Indian Institute of Technology Delhi
- Microbiota sequence variants of tumor-related antigenic epitopes7 Mar 2024US 2024/0075117 A1Enterome S.A.
- Recombinant Miropin15 Feb 2024US 2024/0051991 A1Jagiellonian University
- Method for reducing bioburden of cyclic lipopeptide compound1 Feb 2024US 2024/0033382 A1Kaneka Corporation
- Compositions and methods for non-myeloablative conditioning16 Dec 2021US 2021/0388094 A1Children's Medical Center Corporation
- Addition of nucleases directly to cell culture to facilitate digestion and clearance of host cell nucleic acids17 Dec 2020US 2020/0392468 A1Merck Sharp & Dohme Corp.
Most cited
By later US patents
- Transcutaneous delivery of therapeutic agents49US 8,728,491 B2Alba Therapeutics Corporation · 2014
- Lactic acid bacteria, antibacterial substance produced by the bacteria, fermented milk starter containing the bacteria, and process for producing fermented milk by using the starter25US 5,482,723 ASnow Brand Milk Products Co., Ltd. · 1996
- Lactic acid bacteria, antibacterial substance produced by the bacteria, fermented milk starter containing the bacteria, and process for producing fermented milk by using the starter18US 5,338,682 ASnow Brand Milk Products Co., Ltd. · 1994
- Propionibacteria peptide microcin15US 5,635,484 AState of Oregon acting by and through the Oregon State Board of Higher Education on behalf of Oregon State University · 1997
- Compositions and methods for non-myeloablative conditioning8US 10,280,225 B2Children's Medical Center Corporation · 2019